We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Ligand Enters into Screening Agreement with Trevena

News   Feb 10, 2009

 
Ligand Enters into Screening Agreement with Trevena
 
 
Advertisement
 

RELATED ARTICLES

How Parkinson's Protein Destroys Cell Membranes

News

A newly developed method has revealed how the composition of cell membranes seems to be a decisive factor for how small quantities of α-synuclein cause damage.

READ MORE

Asthma Drug Salbutamol Inhibits Tau Filament Formation In Vitro

News

A new study suggests that the common asthma drug called salbutamol may offer potential as a treatment for Alzheimer’s disease. Extensive analytical in vitro experiments show that salbutamol is effective at reducing the accumulation of insoluble fibres of the tau protein – which is found in the brains of people with Alzheimer’s disease.

READ MORE

Novel Pathology Could Improve Diagnosis and Treatment of Huntington’s Disease

News

Researchers have discovered a novel pathology that occurs in several human neurodegenerative diseases, including Huntington’s disease, and could be used to improve their diagnosis and treatment.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE